Evaluation and biological properties of reactive ligands for the mapping of the glycine site on the N-methyl-D-aspartate (NMDA) receptor

Journal of Medicinal Chemistry

Volumn 42, Issue 21, 1999, Pages 4394-4404

  Kreimeyer, Annett ^a   Laube, Bodo ^b   Sturgess, Mike ^c   Goeldner, Maurice ^a   Foucaud, Bernard ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

^c Bearsden Bio Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; 7 CHLORO 4 HYDROXY 3 PHENYL 2 QUINOLONE; GLYCINE; LIGAND; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG CONFORMATION; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING, COMPETITIVE; BRAIN; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; LIGANDS; OOCYTES; QUINOLINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS LAEVIS;

EID: 0032724199     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9910730     Document Type: Article

References (57)

1. Daw, N. W.; Stein, P. S. G.; Fox, K. The role of NMDA receptors in information processing. Annu. Rev. Neurosci. 1993, 16, 207-222.
2. McBain, C. J.; Mayer, M. L. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 1994, 74, 723-760.
3. Leeson, P. D.; Baker, R.; Carling, R. W.; Curtis, N. R.; Moore, K. W.; Williams, B. J.; Foster, A. C.; Donald, A. E.; Kemp, J. A.; Marshall, G. R. Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor. J. Med. Chem. 1991, 34, 1343-1352.
4. Leeson, P. D.; Iversen, L. L. The glycine site on the NMDA receptor: Structure activity relationships and therapeutic potentials. J. Med. Chem. 1994, 37, 4053-4067.
5. Kuryatov, A.; Laube, B.; Betz, H.; Kuhse, J. Mutational analysis of the glycine-binding site of the NMDA receptor: Structural similarity with bacterial amino acid-binding proteins. Neuron 1994, 12, 1291-1300.
6. Hirai, H.; Kirsch, J.; Laube, B.; Betz, H.; Kuhse, J. The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: Identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region. Proc. Natl. Acad. Sci. U.S.A 1996, 93, 6031-6036.
7. Laube, B.; Hirai, H.; Sturgess, M.; Betz, H.; Kuhse, J. Molecular determinants of agonist discrimination by NMDA receptor subunites: Analysis of the glutamate binding site on the NR2B subunit. Neuron 1997, 18, 493-503.
8. Wafford, K. A.; Kathoria, M.; Bain, M. J.; Marshall, G.; Lebourdelles, B.; Kemp, J. A.; Whiting, P. J. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site. Mol. Pharmacol. 1995, 47, 374-380.
9. Williams, K.; Chao, J.; Kashiwagi, K.; Masuko, T.; Igarashi, K. Activation of N-methyl-D-aspartate receptors by glycine: Role of an aspartate residue in the M3-M4 loop of the NR1 subunit. Mol. Pharmacol. 1996, 50, 701-708.
10. Wood, M. W.; VanDongen, H. M. A.; VanDongen, A. M. J. An alanine residue in the M3-M4 linker lines the glycine binding pocket of the N-methyl-D-aspartate receptor. J. Biol. Chem. 1997, 272, 3532-3537.
11. Paas, Y. The macro- and microarchitecture of the ligand-binding domain of glutamate receptors. Trends Neurosci. 1998, 21, 117-125.
12. Uchino, S.; NakajimaLijima, S.; Okuda, K; Mishina, M.; Kawamoto, S. Analysis of the glycine binding domain of the NMDA receptor channel zeta 1 subunit. Neuroreport 1997, 8, 445-449.
13. Ivanovic, A.; Reilhänder, H.; Laube, B.; Kuhse, J. Expression and initial characterization of a soluble glycine binding domain of the N-methyl-D-aspartate receptor NR1 subunit. J. Biol. Chem. 1998, 273, 19933-19937.
14. Plapp, B. V. Application of affinity labeling for studying structure and function of enzymes. In Methods in Enzymology, vol. 87: Enzyme kinetics and mechanism, part C; Purich, D. L., Ed.; Academic Press: New York, 1982; pp 469-499.
15. Newman, A. H. Irreversible ligands as probes for drug receptors. NIDA Res. Monogr. 1991, 112, 256-283.
16. Laurie, D. J.; Seeburg, P. H. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. Mol. Pharm. 1994, 268, 335-345.
17. Chazot, P. L.; Reiss, C.; Chopra, B.; Stephenson, F. A. [H-3]MDL 105,519 binds with equal high affinity to both assembled and unassembled NR1 subunits of the NMDA receptor. Eur. J. Pharmacol. 1998, 353, 137-140.
18. Grimwood, S.; Kulagowski, J. J.; Mawer, L. M.; Rowley, M.; Leeson, P. D.; Foster, A. C. Allosteric modulation of the glutamate site on the NMDA receptor by four novel glycine site antagonists. Eur. J. Pharmacol. Mol. Pharm. 1995, 290, 221-226.
19. Ishii, T.; Moriyoshi, K.; Sugihara, H.; Sakurada, K.; Kadotani, H.; Yokoi, M.; Akazawa, C.; Shigemoto, R.; Mizuno, N.; Masu, M.; Nakanishi, S. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 1993, 268, 2836-2843.
20. Kulagowski, J. J.; Baker, R.; Curtis, R. R.; Leeson, P. D.; Mawer, I. M.; Moseley, A. M.; Ridgill, M. P.; Rowley, M.; Stansfield, I.; Foster, A. C.; Grimwood, S.; Hill, R. G.; Kemp, J. A.; Marshall, G. R.; Saywell, K. L.; Tricklebank, M. D. 3′-(Arylmethyl)- and 3′-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor. J. Med. Chem. 1994, 37, 1402-1405.
21. Grimwood, S.; Lebourdelles, B.; Whiting, P. G. Recombinant human NMDA homomeric NR1 receptors expressed in mammalian cells form a high-affinity glycine antagonist binding site. J. Neurochem. 1995, 64, 525-530.
22. Carling, R. W.; Leeson, P. D.; Moore, K. W.; Moyes, C. R.; Duncton, M.; Hudson, M. L.; Baker, L.; Foster, A. C.; Grimwood, S.; Kemp, J. A.; Marshall, G. R.; Tricklebank, M. D.; Saywell, K. L. 4-Substituted-3-phenylquinolin-2(1H)-ones: Acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity. J. Med. Chem. 1997, 40, 754-765.
23. Kreimeyer, A.; Laube, B.; Sturgess, M.; Goeldner, M.; Foucaud, B. Reactive affinity probes for the mapping of the glycine-binding site of the NMDA receptor NR1 subunit. J. Recept. Signal Tr. R. 1999, 19, 547-557
24. Colas, C.; Goeldner, M. Efficient procedure of the synthesis of crystalline aryldiazonium trifluoroacetates. Synthetic application. Eur. J. Org. Chem. 1999, 1357-1366.
25. Krutak, J. J.; Burpitt, R. D.; Moore, W. H.; Hyatt, J. A. Chemistry of ethenesulfonyl fluoride. Fluorosulfonylethylation of organic compounds. J. Org. Chem. 1979, 44, 3847-3858.
26. Rychnovsky, S. D.; Hwang, K. Synthesis of (±)-combretastatin D-1 and combretastatin D-2. J. Org. Chem, 1994, 59, 5414-5418.
27. Campagna, F.;. Carotti, A.; Casini, G. A convenient synthesis of nitrites from primary amides under mild conditions. Tetrahedron Lett. 1997, 21, 1813-1816.
28. Danysz, W.; Fadda, E.; Wroblewski, J. T.; Costa, E. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptor. Mol. Pharmacol. 1989, 36, 912-916.
29. Jimonet, P.; Audiau, F.; Aloup, J. C.; Barreau, M.; Blanchard, J. C.; Bohme, A.; Boireau, A.; Cheve, M.; Damour, D.; Doble, A.; Lavayre, J.; Dutrucrosset, G.; Randle, G. C. R.; Rataud, J.; Stutzmann, J. M.; Mignani, S. Synthesis and SAR of 2H-1,2,4-benzothiadiazine-,1,1-dioxide-3-carboxylic acid derivatives as novel potent glycine antagonists of the NMDA receptor-channel complex. Bioorg. Med. Chem. Lett. 1994, 4, 2735-2740.
30. Monyer, H.; Burnashev, N.; Laurie, D. J.; Sakmann, B.; Seeburg, P. H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12, 529-540.
31. Auberson, Y. P.; Acklin, P.; Allgeier, H.; Biollaz, M.; Bischoff, S.; Ofner, S.; Veenstra, S. J. 5-Aminomethylquinoxaline-2,3-diones. Part II: N-aryl derivatives as novel NMDA/glycine and AMPA antagonists. Bioorg. Med. Chem. Lett. 1998, 8, 71-74.
32. Cai, S. X.; Zhou, Z. L.; Huang, J. C.; Whittemore, E. R.; Egbuwoku, Z. O.; Lu, Y. X.; Hawkinson, J. E.; Woodward, R. M.; Weber, E.; Keana, J. F. W. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: Novel and highly potent antagonists for NMDA receptor glycine site. J. Med. Chem. 1996, 39, 3248-3255.
33. Colotta, V.; Catarzi, D.; Varano, F.; Cecci, L.; Filacchioni, G.; Galli, A.; Costagli, C. Synthesis and biological evaluation of a series of quinoxaline-2-carboxilic acids and quinazoline-2,4-diones as glycine-NMDA antagonists: A pharmacophore model based approach. Arch. Pharm. 1997, 330, 129-134.
34. McQuaid, L. A.; Smith, E. C. R.; Lodge, D.; Pralong, E.; Wikel, J. H.; Calligaro, D. O.; Omalley, P. J. 3-Phenyl-4-hydroxyquinolin-2(1H)-ones - Potent and selective antagonists at the strychnine-insensitive glycine site on the N-Methyl-D-aspartate receptor complex. J. Med. Chem. 1992, 35, 3423-3425.
35. MacLeod, A. M.; Grimwood, S.; Barton, C.; Bristow, L.; Saywell, K. L.; Marshall, G. R.; Ball, R. G. Identification of 3,5-dihydro-2-aryl-1H-pyrazolo[3,4-c]quinoline-1,4(2H)-diones as novel high-affinity glycine site N-methyl-D-aspartate antagonists. J. Med. Chem. 1995, 38, 2239-2243.
36. Rowley, M.; Leeson, P. D.; Stevenson, G. I.; Moseley, A. M.; Stansfiled, I.; Sanderson, I.; Robinson, L.; Baker, R.; Kemp, J. A.; Marshall, G. R.; Foster, A. C.; Grimwood, S.; Tricklebank, M. D.; Saywell, K. L. 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systematically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex. J. Med. Chem. 1993, 36, 3386-3396.
37. Cai, S. X.; Kher, S. M.; Zhou, Z. L.; Ilyin, V.; Espitia, S. A.; Tran, M.; Hawkinson, J. E.; Woodward, R. M.; Weber, E.; Keana, J. F. W. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: Potent and systemically active antagonists for the glycine site of the NMDA receptor. J. Med. Chem. 1997, 40, 730-738.
38. Bigge, C. F.; Malone, T. C.; Boxer, P. A.; Nelson, C. B.; Ortwine, D. F.; Schelkun, R. M.; Retz, M. D.; Lescosky, L. J.; Borosky, S. A.; Vartanian, M. G.; Schwarz, R. D.; Campbell, J. W.; Robichaud, L. J.; Wätjen, F. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]-quinoxaline-2,3-dione and related quinoxalinediones: characterization of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity. J. Med. Chem. 1995, 38, 3720-3740.
39. Ohmori, J.; Kubota, H.; Shimisu-Sasamata, M.; Okada, M.; Sakamoto, S. Novel α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonists: Synthesis and structure-activity relationships of 6-(1H-imidazole-1-yl)-7-nitro-2,3(1H,-4H)-pyrido[2,3-b]pyrazinedione and related compounds. J. Med. Chem. 1998, 39, 1331-1338.
40. Leeson, P. D. Glycine-site N-methyl-D-aspartate receptor antagonists. In Drug Design for Neuroscience; Kozikowski, A. P., Ed.; Raven Press: New York, 1993; pp 339-381.
41. Durand, G. M.; Gregor, P.; Zheng, X.; Bennett, M. V. L.; Uhl, G. R.; Zukin, R. S. Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase-C. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 9359-9363.
42. Parsons, C. G.; Danysz, W.; Quack, G.; Hartmann, S.; Lorenz, B.; Wollenburg, C.; Baran, L.; Przegalinski, E.; Kostowski, W.; Krzascik, P.; Chizh, B.; Headley, P. M. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: Electrophysiological, biochemical and behavioral characterization. J. Pharmacol. Exp. Ther. 1997, 283, 1264-1275.
43. When a 10 μM solution of 13e (stock solution 10 mM in DMSO) is kept in frog's Ringer for 1 h at room temperature its UV absorbance decreases of 16% at all wavelengths, which can be attributed to partial precipitation.
44. Colman, R. F. Affinity labeling of purine nucleotide sites in proteins. Annu. Rev. Biochem. 1983, 52, 67-91
45. Likos, J. J.; Hess, B.; Colman, R. F. Affinity labeling of the active site of yeast pyruvate kinase by 5′-p-fluorosulfonylbenzoyl adenosine. J. Biol. Chem. 1980, 255, 9388-9398.
46. 3H]-inosine is accompanied by modification of tyrosine 345 in a single β subunit. J. Biol. Chem. 1986, 261, 14171-14177.
47. Tomich, J. M.; Marti, C.; Colman, R. F. Modification of two essential cysteines in rabbit muscle pyruvate kinase by the guanine nucleotide analogue 5′-[p-(fluorosulfonyl)benzoyl]guanosine. Biochemistry 1981, 20, 6711-6720.
48. Fahrney, D. E.; Gold, A. M. Sulfonyl fluorides as inhibitors of esterases. I. Rates of reaction with acetylcholinesterase, α-chymotrypsin, and trypsin. J. Am. Chem. Soc. 1962, 85, 997-1000.
49. Poulos, T. L.; Price, P. A. The involvement of serine and carboxyl groups in the activity of bovine pancreatic deoxyribonuclease A. J. Biol. Chem. 1974, 249, 1453-1457.
50. Armstrong, N.; Sun, Y.; Chen, G.-Q.; Gouaux, E. Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature 1998, 395, 913-917.
51. Settimo, A. D.; Saettone, M. F. The nitration of some methyl substituted indole-3-aldehydes in sulphuric acid. Tetrahedron 1965, 21, 1923-1929.
52. 1 Photolysis of 6,11-dihydro-11-oxodibenz[b,e]oxepin-3-acetic acid. Chem. Pharm. Bull. 1984, 8, 3047-3052.
53. Archer, J. G.; Barker, A. J.; Smalley, R. K. 1,2,3-Benzotriazin-4-ones and related Systems. Part II. 1 Thermolytic decomposition of substituted 1,2,3-benzotriazin-4-ones and isatoic anhydrides. J. Chem. Soc., Perkin Trans, 1 EN 1973, 1169-1173.
54. 1 Photoinduced ring expansions of o-azidobenzonitriles to 3-cyano- and 7-cyano-3H-azepin-2(1H)-ones. Tetrahedron 1994, 50, 5515-5526.
55. Rosowsky, A.; Marini, J. L.; Nadel, M. E.; Modest, E. J. Quinazolines. VI. Synthesis of 2,4-diaminoquinazolines from anthranilonitriles. J. Med. Chem. 1970, 13, 882-886.
56. Some of the values in Table 1 are at variance from those reported earlier in ref 23. Since fresh solutions had not been used systematically in the preliminary experiments, we suspect that the solute might have been decomposed or precipitated in the buffer before the binding assays reported in ref 23.
57. Bowen, W. P.; Jerman, J. C. Nonlinear regression using spreadsheets. Trends Pharmacol. Sci. 1995, 16, 413-417.